XML 132 R120.htm IDEA: XBRL DOCUMENT v3.5.0.2
Guarantor Financial Information (Condensed Consolidated Statement of Cash Flows) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net Cash Provided by (Used in) Operating Activities $ 2,337.0 $ 4,228.4 $ 1,463.0
CASH FLOWS FROM INVESTING ACTIVITIES:      
Movements in restricted cash (32.0) (32.6) (5.3)
Purchases of subsidiary undertakings and businesses, net of cash acquired (5,553.4) (4,104.4) (227.8)
Purchases of non-current investments (9.5) (23.1) (10.6)
Proceeds from short-term investments 67.0 57.8 0.0
Proceeds received on sale of product rights 17.5 127.0 19.2
Proceeds from disposal of non-current investments 18.7 21.5 12.1
Other, net (13.5) 0.2 8.5
Net Cash Provided by (Used in) Investing Activities (5,619.9) (4,030.6) (360.9)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from revolving line of credit, long-term and short-term borrowings 3,760.8 2,310.8 0.0
Repayment of lines of credit (3,110.9) (1,461.8) 0.0
Payment of dividend (134.4) (121.2) (96.4)
Excess tax benefit associated with exercise of stock options 32.4 39.7 13.4
Facility arrangement fee (24.1) (10.2) (13.9)
Contingent consideration payments (101.2) (15.2) (14.1)
Other, net (0.2) (0.2) (7.0)
Net cash provided by/(used in) financing activities 439.0 554.5 (344.6)
Effect of foreign exchange rate changes on cash and cash equivalents (3.0) (9.3) (0.3)
Cash and Cash Equivalents, Period Increase (Decrease) (2,846.9) 743.0 757.2
Cash and cash equivalents at beginning of period 2,982.4 2,239.4 1,482.2
Cash and cash equivalents at end of period 135.5 2,982.4 2,239.4
Consolidation, Eliminations [Member]      
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net Cash Provided by (Used in) Operating Activities 0.0 0.0 0.0
CASH FLOWS FROM INVESTING ACTIVITIES:      
Net transactions with subsidiaries 6,618.2 1,441.7 0.0
Movements in restricted cash 0.0 0.0
Purchases of subsidiary undertakings and businesses, net of cash acquired 0.0 0.0
Purchases of non-current investments 0.0 0.0 0.0
Proceeds received on sale of product rights 0.0 0.0
Other, net 0.0 0.0 0.0
Net Cash Provided by (Used in) Investing Activities 6,618.2 1,441.7
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from revolving line of credit, long-term and short-term borrowings 0.0 0.0 0.0
Repayment of lines of credit 0.0 0.0 0.0
Net proceeds from/(to) intercompany borrowings (6,618.2) (1,441.7)
Payment of dividend 0.0 0.0
Excess tax benefit associated with exercise of stock options 0.0 0.0
Facility arrangement fee 0.0 0.0 0.0
Contingent consideration payments 0.0 0.0
Other, net 0.0 0.0 0.0
Net cash provided by/(used in) financing activities (6,618.2) (1,441.7) 0.0
Effect of foreign exchange rate changes on cash and cash equivalents 0.0
Cash and Cash Equivalents, Period Increase (Decrease) 0.0 0.0
Cash and cash equivalents at beginning of period 0.0 0.0
Cash and cash equivalents at end of period 0.0 0.0 0.0
Consolidated      
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net Cash Provided by (Used in) Operating Activities 2,337.0 4,228.4 1,463.0
CASH FLOWS FROM INVESTING ACTIVITIES:      
Net transactions with subsidiaries 0.0 0.0 0.0
Movements in restricted cash 32.0 32.6 5.3
Purchases of subsidiary undertakings and businesses, net of cash acquired 5,553.4 4,104.4 227.8
Purchases of non-current investments 124.2 100.1 167.6
Proceeds received on sale of product rights 17.5 127.0 19.2
Other, net (72.2) (79.5) (20.6)
Net Cash Provided by (Used in) Investing Activities (5,619.9) (4,030.6) (360.9)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from revolving line of credit, long-term and short-term borrowings 3,760.8 2,310.8 0.0
Repayment of lines of credit 3,110.9 1,461.8 0.0
Net proceeds from/(to) intercompany borrowings 0.0 0.0
Payment of dividend 134.4 121.2 96.4
Excess tax benefit associated with exercise of stock options 32.4 39.7 13.4
Facility arrangement fee 24.1 10.2 0.0
Contingent consideration payments 101.2 15.2 14.1
Other, net 16.4 (187.6) (247.5)
Net cash provided by/(used in) financing activities 439.0 554.5 (344.6)
Effect of foreign exchange rate changes on cash and cash equivalents (3.0) (9.3) (0.3)
Cash and Cash Equivalents, Period Increase (Decrease) (2,846.9) 743.0 757.2
Cash and cash equivalents at beginning of period 2,982.4 2,239.4 1,482.2
Cash and cash equivalents at end of period 135.5 2,982.4 2,239.4
Shire Plc ( Parent Guarantor)      
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net Cash Provided by (Used in) Operating Activities (133.5) 1,512.6 (78.2)
CASH FLOWS FROM INVESTING ACTIVITIES:      
Net transactions with subsidiaries (3,570.0) (1,900.0) 0.0
Movements in restricted cash 0.0 0.0
Purchases of subsidiary undertakings and businesses, net of cash acquired 0.0 0.0
Purchases of non-current investments 0.0 0.0 0.0
Proceeds received on sale of product rights 0.0 0.0 0.0
Other, net 0.0 0.0 0.0
Net Cash Provided by (Used in) Investing Activities (3,570.0) (1,900.0) 0.0
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from revolving line of credit, long-term and short-term borrowings 3,760.0 2,310.0 0.0
Repayment of lines of credit 3,110.0 1,460.0 0.0
Net proceeds from/(to) intercompany borrowings 3,048.2 (458.3) 259.8
Payment of dividend 6.8 8.9 5.7
Excess tax benefit associated with exercise of stock options 0.0 0.0
Facility arrangement fee 4.5 10.6 0.0
Contingent consideration payments 0.0 0.0
Other, net 16.6 15.2 (175.9)
Net cash provided by/(used in) financing activities 3,703.5 387.4 78.2
Effect of foreign exchange rate changes on cash and cash equivalents 0.0 0.0 0.0
Cash and Cash Equivalents, Period Increase (Decrease) 0.0 0.0 0.0
Cash and cash equivalents at beginning of period 0.0 0.0 0.0
Cash and cash equivalents at end of period 0.0 0.0 0.0
SAIIDAC ( Subsidiary issuer)      
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net Cash Provided by (Used in) Operating Activities 0.0 0.0
CASH FLOWS FROM INVESTING ACTIVITIES:      
Net transactions with subsidiaries 0.0 0.0 0.0
Movements in restricted cash 0.0 0.0
Purchases of subsidiary undertakings and businesses, net of cash acquired 0.0 0.0
Purchases of non-current investments 0.0 0.0 0.0
Proceeds received on sale of product rights 0.0 0.0 0.0
Other, net 0.0 0.0 0.0
Net Cash Provided by (Used in) Investing Activities 0.0 0.0 0.0
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from revolving line of credit, long-term and short-term borrowings 0.0 0.0 0.0
Repayment of lines of credit 0.0 0.0 0.0
Net proceeds from/(to) intercompany borrowings
Payment of dividend 0.0 0.0
Excess tax benefit associated with exercise of stock options 0.0 0.0
Facility arrangement fee 0.0 0.0 0.0
Contingent consideration payments 0.0 0.0
Other, net 0.0 0.0 0.0
Net cash provided by/(used in) financing activities 0.0 0.0 0.0
Effect of foreign exchange rate changes on cash and cash equivalents 0.0 0.0 0.0
Cash and Cash Equivalents, Period Increase (Decrease) 0.0 0.0 0.0
Cash and cash equivalents at beginning of period 0.0 0.0 0.0
Cash and cash equivalents at end of period 0.0 0.0 0.0
Baxalta (Subsidiary Issuer)      
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net Cash Provided by (Used in) Operating Activities 0.0 0.0
CASH FLOWS FROM INVESTING ACTIVITIES:      
Net transactions with subsidiaries 0.0 0.0 0.0
Movements in restricted cash 0.0 0.0
Purchases of subsidiary undertakings and businesses, net of cash acquired 0.0 0.0
Purchases of non-current investments 0.0 0.0 0.0
Proceeds received on sale of product rights 0.0 0.0 0.0
Other, net 0.0 0.0 0.0
Net Cash Provided by (Used in) Investing Activities 0.0 0.0 0.0
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from revolving line of credit, long-term and short-term borrowings 0.0 0.0 0.0
Repayment of lines of credit 0.0 0.0 0.0
Net proceeds from/(to) intercompany borrowings
Payment of dividend 0.0 0.0
Excess tax benefit associated with exercise of stock options 0.0 0.0
Facility arrangement fee 0.0 0.0 0.0
Contingent consideration payments 0.0 0.0
Other, net 0.0 0.0 0.0
Net cash provided by/(used in) financing activities 0.0 0.0 0.0
Effect of foreign exchange rate changes on cash and cash equivalents 0.0 0.0 0.0
Cash and Cash Equivalents, Period Increase (Decrease) 0.0 0.0 0.0
Cash and cash equivalents at beginning of period 0.0 0.0 0.0
Cash and cash equivalents at end of period 0.0 0.0 0.0
Non-Guarantor Non-Issuer Subsidiaries      
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net Cash Provided by (Used in) Operating Activities 2,470.5 2,715.8 1,541.2
CASH FLOWS FROM INVESTING ACTIVITIES:      
Net transactions with subsidiaries (3,048.2) 458.3 0.0
Movements in restricted cash 32.0 32.6 5.3
Purchases of subsidiary undertakings and businesses, net of cash acquired 5,553.4 4,104.4 227.8
Purchases of non-current investments 124.2 100.1 167.6
Proceeds received on sale of product rights 17.5 127.0 19.2
Other, net (72.2) (79.5) (20.6)
Net Cash Provided by (Used in) Investing Activities (8,668.1) (3,572.3) (360.9)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from revolving line of credit, long-term and short-term borrowings 0.8 0.8 0.0
Repayment of lines of credit 0.9 1.8 0.0
Net proceeds from/(to) intercompany borrowings 3,570.0 1,900.0 (259.8)
Payment of dividend 127.6 112.3 90.7
Excess tax benefit associated with exercise of stock options 32.4 39.7 13.4
Facility arrangement fee 19.6 (0.4) 0.0
Contingent consideration payments 101.2 15.2 14.1
Other, net (0.2) (202.8) (71.6)
Net cash provided by/(used in) financing activities 3,353.7 1,608.8 (422.8)
Effect of foreign exchange rate changes on cash and cash equivalents (3.0) (9.3) (0.3)
Cash and Cash Equivalents, Period Increase (Decrease) (2,846.9) 743.0 757.2
Cash and cash equivalents at beginning of period 2,982.4 2,239.4 1,482.2
Cash and cash equivalents at end of period 135.5 2,982.4 2,239.4
Non-Guarantor Subsidiaries of SAIIDAC      
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net Cash Provided by (Used in) Operating Activities 2,470.5 2,715.8 1,541.2
CASH FLOWS FROM INVESTING ACTIVITIES:      
Net transactions with subsidiaries (3,048.2) 458.3 0.0
Movements in restricted cash 32.0 32.6 5.3
Purchases of subsidiary undertakings and businesses, net of cash acquired 5,553.4 4,104.4 227.8
Purchases of non-current investments 124.2 100.1 167.6
Proceeds received on sale of product rights 17.5 127.0 19.2
Other, net (72.2) (79.5) (20.6)
Net Cash Provided by (Used in) Investing Activities (8,668.1) (3,572.3) (360.9)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from revolving line of credit, long-term and short-term borrowings 0.8 0.8 0.0
Repayment of lines of credit 0.9 1.8 0.0
Net proceeds from/(to) intercompany borrowings 3,570.0 1,900.0 (259.8)
Payment of dividend 127.6 112.3 90.7
Excess tax benefit associated with exercise of stock options 32.4 39.7 13.4
Facility arrangement fee 19.6 (0.4) 0.0
Contingent consideration payments 101.2 15.2 14.1
Other, net (0.2) (202.8) (71.6)
Net cash provided by/(used in) financing activities 3,353.7 1,608.8 (422.8)
Effect of foreign exchange rate changes on cash and cash equivalents (3.0) (9.3) (0.3)
Cash and Cash Equivalents, Period Increase (Decrease) (2,846.9) 743.0 757.2
Cash and cash equivalents at beginning of period 2,982.4 2,239.4 1,482.2
Cash and cash equivalents at end of period 135.5 2,982.4 2,239.4
Non-Guarantor Subsidiaries of Baxalta      
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net Cash Provided by (Used in) Operating Activities 2,470.5 2,715.8 1,541.2
CASH FLOWS FROM INVESTING ACTIVITIES:      
Net transactions with subsidiaries (3,048.2) 458.3 0.0
Movements in restricted cash 32.0 32.6 5.3
Purchases of subsidiary undertakings and businesses, net of cash acquired 5,553.4 4,104.4 227.8
Purchases of non-current investments 124.2 100.1 167.6
Proceeds received on sale of product rights 17.5 127.0 19.2
Other, net (72.2) (79.5) (20.6)
Net Cash Provided by (Used in) Investing Activities (8,668.1) (3,572.3) (360.9)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from revolving line of credit, long-term and short-term borrowings 0.8 0.8 0.0
Repayment of lines of credit 0.9 1.8 0.0
Net proceeds from/(to) intercompany borrowings 3,570.0 1,900.0 (259.8)
Payment of dividend 127.6 112.3 90.7
Excess tax benefit associated with exercise of stock options 32.4 39.7 13.4
Facility arrangement fee 19.6 (0.4) 0.0
Contingent consideration payments 101.2 15.2 14.1
Other, net (0.2) (202.8) (71.6)
Net cash provided by/(used in) financing activities 3,353.7 1,608.8 (422.8)
Effect of foreign exchange rate changes on cash and cash equivalents (3.0) (9.3) (0.3)
Cash and Cash Equivalents, Period Increase (Decrease) (2,846.9) 743.0 757.2
Cash and cash equivalents at beginning of period 2,982.4 2,239.4 1,482.2
Cash and cash equivalents at end of period $ 135.5 $ 2,982.4 $ 2,239.4